Transforming growth factor-beta binds reversibly in vitro to Guglielmi detachable coils

被引:2
|
作者
Kallmes, DF
Hankins, GR
Borland, MK
Cloft, HJ
Jensen, ME
Dion, JE
Hell, GA
机构
[1] Univ Virginia, Hlth Sci Ctr, Dept Radiol, Charlottesville, VA 22908 USA
[2] Univ Virginia, Hlth Sci Ctr, Dept Neurol Surg, Charlottesville, VA 22908 USA
关键词
Guglielmi detachable coil; transforming growth factor; in vitro;
D O I
10.1177/159101999800400102
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We determined the propensity for and reversibility of transforming growth factor-beta (TGF beta) binding to uncoated Guglielmi Detachable Coils (GDC) and to GDC coated with extracellular matrix (ECM) proteins. Three 1.0 centimetre samples each of uncoated GDC-18 and of GDC-18 coated with either poly-L-lysine, laminin, type I collagen, type IV collagen, fibronectin, or poly-L-lysine and laminin were prepared. These samples were immersed briefly in a solution containing I-125-labelled TGF beta at a concentration of 0.225 mu g/ml with initial specific activity of 123.3 mCi/mg (DuPont-NEN, Billerica, MA), and were counted using a scintillation counter. Each sample was then placed in a vial containing saline shaken for 60 seconds, and counted again. Selected samples were immersed for varying periods within the TGF beta solution and counted before and after saline rinse. Samples were rinsed one week after initial rinsing and counted again. The amount of binding between coil types was compared using the Student t test. For all samples initial binding of TGF beta was in the order of 60-120 pg/cm. For the pre-rinse data there were no statistically significant differences between the amount bound to any single coil coating type relative to other coatings. Compared to the initial accumulations, the amount remaining after rinsing ranged from 40% (poly-L-lysine) to 63% (poly-L-lysine with laminin), with a mean of 55% among the seven coil types. After rinsing there was more growth factor remaining on uncoated coils than on poly-L-lysine-coated coils (p=0.05), fibronectin-coated coils (p=0.01), and type IV collagen-coated coils (p=0.04). There was a trend toward greater residual growth factor on coils coated with poly-L-lysine and laminin compared to coils coated with poly-L-lysine alone (p=0.10). Delayed second rinsing of the samples one week after initial testing demonstrated only minor incremental loss of TGF beta from the coil surfaces. After five minutes of immersion, accumulation was approximately 200% greater than that noted with brief submersion, but immersions lasting over five minutes did not yield increasing levels of TGF beta binding. TGF beta binds to GDC coils. Binding is not improved with ECM protein-coated coils compared to uncoated coils. The absolute amount of TGF beta bound to the coil will likely result in local concentrations of growth factor in the order of those required for biological activity in vivo.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [21] Oral mucosal permeability and stability of transforming growth factor beta-3 in vitro
    Squier, CA
    Kremer, MJ
    Bruskin, A
    Rose, A
    Haley, JD
    PHARMACEUTICAL RESEARCH, 1999, 16 (10) : 1557 - 1563
  • [22] Oral Mucosal Permeability and Stability of Transforming Growth Factor Beta-3 In Vitro
    Christopher A. Squier
    Mary J. Kremer
    Arnold Bruskin
    Ann Rose
    John D. Haley
    Pharmaceutical Research, 1999, 16 : 1557 - 1563
  • [23] Ischemia induced neural stem cell proliferation and differentiation in neonatal rat involved vascular endothelial growth factor and transforming growth factor-beta pathways
    Sun, Jinqiao
    Zhou, Wenhao
    Sha, Bin
    Yang, Yi
    BRAIN & DEVELOPMENT, 2010, 32 (03): : 191 - 200
  • [24] The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk
    Krippl, P
    Langsenlehner, U
    Renner, W
    Yazdani-Biuki, B
    Wolf, G
    Wascher, TC
    Paulweber, B
    Bahadori, B
    Samonigg, H
    CANCER LETTERS, 2003, 201 (02) : 181 - 184
  • [25] Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
    Devan, Aswathy R.
    Pavithran, Keechilat
    Nair, Bhagyalakshmi
    Murali, Maneesha
    Nath, Lekshmi R.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (36) : 5250 - 5264
  • [26] Cartilage regeneration using transforming growth factor-beta 3-loaded injectable crosslinked hyaluronic acid hydrogel
    Lee, Ju Hwa
    Kim, Pil Yun
    Pyun, Yun Chang
    Park, Jonggyu
    Kang, Tae Woong
    Seo, Jin Sol
    Lee, Dae Hoon
    Khang, Gilson
    BIOMATERIALS SCIENCE, 2024, 12 (02) : 479 - 494
  • [27] Effects of transforming growth factor-beta (TGF-β1) on satellite cell activation and survival during oxidative stress
    Christopher R. Rathbone
    Keitaro Yamanouchi
    Xiaoyu K. Chen
    Cedrine J. Nevoret-Bell
    Robert P. Rhoads
    Ronald E. Allen
    Journal of Muscle Research and Cell Motility, 2011, 32 : 99 - 109
  • [28] Impairment of arterial elastic properties and elevated circulating levels of transforming growth factor-beta in subjects with repaired coarctation of aorta
    Brili, Stella
    Antonopoulos, Alexios S.
    Oikonomou, Evangelos
    Kalampogias, Aimilios
    Papamikroulis, George-Angelos
    Chrysochoou, Christina
    Mourouzis, Kostas
    Nihoyanopoulos, Petros
    Tousoulis, Dimitris
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 207 : 282 - 283
  • [29] Effects of transforming growth factor-beta-1 neutralizing antibody and transforming growth factor-beta-3 on the development of tracheal stenosis
    Elicora, Aykut
    Ozcelikay, Goksu
    Sezer, Huzeyin Fatih
    Liman, Serife Tuba
    Yildiz, Kursat
    Topcu, Salih
    Arica, Betul
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 25 (03): : 433 - 438
  • [30] Transforming Growth Factor-Beta Produced by Non-small Cell Lung Cancer Cells Contributes to Lung Fibroblast Contractile Phenotype
    Kanaji, Nobuhiro
    Yokohira, Masanao
    Watanabe, Naoki
    Kadowaki, Norimitsu
    Bandoh, Shuji
    ANTICANCER RESEARCH, 2018, 38 (04) : 2007 - 2014